CU6 4.55% $6.50 clarity pharmaceuticals ltd

Ann: Initial COBRA results, page-50

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 23,612 Posts.
    lightbulb Created with Sketch. 1492
    After all the discussion about the results I figured I'd better read beyond the highlights section

    " One particular example shows the limitations even for the use of biopsies to validate the 64Cu-SAR-bisPSMA PET findings, where the first biopsy of a lymph node had a negative histopathology result for PC, which turned out positive following the complete excision of the same lymph node (Figure 3, above)"

    I found that rather tasty, 64Cu finding tumours that even biopsies miss
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.